You are here
Articles
Posted on Monday, July 26, 2010 - 12:17pm
Patient advocacy in clinical trials- EHA Congress, June 10-13th, 2010, Barcelona—Though recent developments aim to improve the clinical trial process, a group of...
Posted on Tuesday, July 20, 2010 - 3:01pm
Researchers at Duke University Medical Center have identified a mechanism that could explain how patients move into the worst phase of chronic myelogenous leukemia (CML).
Posted on Monday, July 12, 2010 - 7:13pm
The Pink Sheet Daily, 2010 Jul 5. J Merrill
Posted on Monday, June 28, 2010 - 8:56pm
Bosutinib Induces High Response Rates in Imatinib-Resistant, -Intolerant Patients
Elsevier Global Medical News. 2010 Jun 21, N Osterweil
Posted on Tuesday, June 8, 2010 - 9:48pm
The Pink Sheet Daily. 2010 Jun 7, E Hayes
Posted on Tuesday, June 8, 2010 - 7:36pm
Even Better Kinase Inhibitors for Chronic Myeloid Leukaemia: Charles L. Sawyers, M.D
Posted on Tuesday, June 8, 2010 - 6:39pm
Impact of JAK2V617F-mutation status, allele burden and clearance after allogeneic stem cell transplantation for myelofibrosis
Haefaa Alchalby1, Anita Badbaran1, Tatjana Zabelina1, Guido Kobbe2, Joachim Hahn3, Daniel...
Posted on Thursday, June 3, 2010 - 12:20pm
Conclusion:
Depression is a common problem in oncology, with many possible causal factors, including disease progression, treatment-related toxicities, social issues, and fear about the...
Posted on Wednesday, June 2, 2010 - 6:07pm
ABSTRACT
Background: Tyrosine kinase inhibitors, such as imatinib, are not considered curative for chronic myeloid leukemia – regardless ofthe significant reduction of disease burden during...
Posted on Friday, May 28, 2010 - 1:28pm
Imatinib 800 mg Associated With Faster MMR vs Imatinib 400 mg or Imatinib 400 mg Plus Interferon in Previously Untreated Chronic-Phase CML. June 11, 2010- German CML Study IV: randomized, treatment...
Posted on Tuesday, May 18, 2010 - 11:13am
Functional Activity of the OCT-1 Protein Is Predictive of Long-Term Outcome in Patients With Chronic-Phase Chronic Myeloid Leukemia Treated With Imatinib
J Clin Oncol. 2010 Apr 26; Epub ahead of print, DL White, P Dang...
Posted on Wednesday, May 5, 2010 - 11:11am
Abstract
Although tyrosine kinase inhibitors is effective for dramatically reducing CML cells, it might be difficult to eradicate completely the CML stem cells. We aimed to clarify the safety and effects of WT1 peptide...
Posted on Thursday, April 22, 2010 - 12:35pm
Leukaemia Insights Newsletter: MD Anderson Cancer Center.
Posted on Monday, April 5, 2010 - 10:31pm
<p>
<a class="topleft" href="http://www.gopetition.com/petitions/be-nice-to-cancer-patients/...
Posted on Sunday, March 28, 2010 - 4:08pm
FDA Committee Favors Validated Gene Test Before Considering Targeted Therapy
Elsevier Global Medical News. 2010 Mar 22, K Wachter
- ‹ previous
- 20 of 29
- next ›